InsidersTradesSigma
Discover the detailed record of transactions filed by Loewald Thomas W, Director. Officer active across 2 companies, notably HARVARD BIOSCIENCE INC. In total, 7 disclosures have been logged. The latest transaction was filed on 24 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
7 of 7 declarations
Thomas W. Loewald is a Board Member at Harvard Bioscience Inc. He plays a key role in the governance of the company, contributing to strategy and decision-making. His experience in the biopharmaceutical sector is valuable in guiding Harvard Bioscience in its development and innovation initiatives.